Related Experiment Video
Updated: Jun 20, 2026
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
[Childhood and adult medulloblastoma: what difference?]
L Padovani1, N André, C Carrie
1Département de Radiothérapie, CHU de la Timone-Enfant, 13385 Marseille cedex 5, France. claude@lyon.fnclcc.fr
Insights
Medulloblastoma, a common childhood brain tumor, now has an 80% five-year survival rate due to advanced treatments. However, long-term survivors often face neurocognitive issues, highlighting the need for careful treatment planning.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Radiation Oncology
Context:
- Medulloblastoma is the most common pediatric brain tumor, representing 30% of cases.
- While survival rates have significantly improved, long-term neurocognitive sequelae are a major concern for childhood survivors.
- Adult medulloblastoma is rare, with limited data on late effects and treatment challenges.
Purpose:
- To review current treatment strategies and outcomes for medulloblastoma in both pediatric and adult populations.
- To highlight the importance of risk-adapted therapy, quality control in radiotherapy, and consideration of late toxicities.
- To discuss the challenges and evolving approaches in managing adult medulloblastoma, including the role of prospective case discussions and new prognostic classifications.
Summary:
- Improved survival for medulloblastoma is attributed to risk-adapted radiation therapy and chemotherapy, with 80% five-year survival in children.
- Neurocognitive deficits are common in pediatric survivors, necessitating careful management of treatment-related toxicities.
- Adult medulloblastoma treatment mirrors pediatric protocols, with initiatives like web conferences aiming to standardize care and improve understanding of this rare adult tumor.
Impact:
- Advances in radiotherapy quality control have reduced recurrence and improved survival rates for childhood medulloblastoma.
- Understanding biological pathways offers new prognostic classifications, enabling tailored therapeutic strategies.
- Standardizing adult medulloblastoma treatment through collaborative efforts holds promise for better outcomes and reduced late effects.
Abstract:
Medulloblastoma is the most frequent childhood brain tumor (30%) but account only for less than 1% of adult brain tumor. The overall survival increased significantly during the last two decades with 80% of long survivors at five years whatever the stage. Most children who survive have significant neurocognitive sequelae. All children are included in national and international prospective studies which propose risk-adapted radiation therapy and chemotherapy after surgery. Quality control of radiotherapy leads to reduce significantly the risk of recurrence and has an impact on survival. Risks of late toxicity should be taken into account at the time of the treatment. Due to the rarety in adult population, no prospective studies and few data about late effects are available. Adult medulloblastoma is a therapeutic challenge and their therapeutic strategies are similar to pediatric protocols. In order to improve the understanding of adult disease and to homogenize the treatment, National Cancer Institute (INCa) stimulated the creation of web conference to discuss each case prospectively and to propose a protocol of treatment. A better comprehension of biological processes and abnormal cellular signalling pathways involved in medulloblastoma pathogenesis had led toward a new prognostic classification to adapt the therapeutic strategy and gives hope of new therapeutic tools.
Related Concept Videos
01:18Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...